ABUS - Arbutus Biopharma Corp
4.29
-0.160 -3.730%
Share volume: 1,383,401
Last Updated: 03-27-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.18%
PREVIOUS CLOSE
CHG
CHG%
$4.45
-0.16
-0.04%
Summary score
38%
Profitability
35%
Dept financing
24%
Liquidity
50%
Performance
40%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 31-Dec-2021 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-10.32%
Return on sales
-719.78%
Return on invested capital
0%
Total debt ratio
25.41%
Debt ratio change over timeo
-1.45%
Current Ratio
8.41%
Quick Ratio
0%
Cash Position Ratio
2.26%
Short-term ratios 31-Dec-2024 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-8.56%
Return on sales
-895.8%
Return on invested capital
0%
Total debt ratio
22.96%
Debt ratio change over timeo
0%
Current Ratio
15.27%
Quick Ratio
0%
Cash Position Ratio
4.17%
Last quarter ratios 31-Dec-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-4.88%
Return on sales
-503.33%
Return on invested capital
0%
Total debt ratio
19.07%
Debt ratio change over time
0%
Current Ratio
15.73%
Quick Ratio
0%
Cash Position Ratio
3%
Performance ratios (change over 4 years) 31-Dec-2021 - 31-Dec-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
-93.1%
Return on sales
29.89%
Return on invested capital
0%
Total debt ratio
-144.65%
Debt ratio change over time
-1.45%
Current Ratio
-8.93%
Quick Ratio
0%
Cash Position Ratio
-4.74%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ABUS | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 12.23% | 10.41% | 0% |
| Return on assets | -10.32% | 4.74% | 3.19% | 1.73% |
| Return on sales | -719.78% | 30.88% | 25.28% | 24.06% |
| Return on invested capital | 0% | 8.04% | 10.95% | 0% |
| Profitability | 0% | 93% | 84% | 29% |
| Total debt ratio | 25.41% | 80.37% | 59.38% | 94.09% |
| Debt ratio change over time | -1.45% | -20.57% | -85.61% | 17.33% |
| Dept financing | 7% | 21% | 16% | 50% |
| Current Ratio | 15.27% | 1.44% | 1.09% | 0.72% |
| Quick Ratio | 0% | 1.12% | 0.84% | 0.6% |
| Cash Position Ratio | 4.17% | 0.16% | 0.44% | 0.14% |
| Liquididy | 50% | 30% | 33% | 24% |
| Short-term ratios | ABUS | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -8.56% | 6.06% | 4.18% | 1.7% |
| Return on sales | -895.8% | 39.61% | 26.91% | 24.78% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 34% | 23% |
| Total debt ratio | 22.96% | 80% | 59.26% | 100.88% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 31% | 20% | 15% | 25% |
| Current Ratio | 15.27% | 1.44% | 1.09% | 0.72% |
| Quick Ratio | 0% | 1.12% | 0.84% | 0.6% |
| Cash Position Ratio | 4.17% | 0.16% | 0.44% | 0.14% |
| Liquididy | 50% | 28% | 23% | 15% |